APO Research
Talk to an analyst

APO RESEARCH · REPORT

Naldemedine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Naldemedine Market Outlook and Growth Opportunities 2026

23 December 2025193 pages

Choose your research edition.

Industry ResearchNaldemedine Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Naldemedine Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Naldemedine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Naldemedine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Naldemedine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Naldemedine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Naldemedine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Naldemedine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Naldemedine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Naldemedine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Naldemedine market include Purdue Pharma and Shionogi among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Naldemedine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Naldemedine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Naldemedine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Naldemedine market size, projected growth trends, production technologies, key applications, and end-use industries.

Naldemedine Segment by Company

Purdue Pharma

Shionogi

Naldemedine Segment by Type

Self-production API

Outsourcing of API

Naldemedine Segment by Application

Clinic

Hospital

Drug Center

Others

Naldemedine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Naldemedine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Naldemedine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Naldemedine significant trends, drivers, influence factors in global and regions.

6. To analyze Naldemedine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Naldemedine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Naldemedine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Naldemedine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Naldemedine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Naldemedine industry.

Chapter 3: Detailed analysis of Naldemedine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Naldemedine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Naldemedine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Naldemedine Industry Trends Table 2. Naldemedine Industry Drivers Table 3. Naldemedine Industry Opportunities and Challenges Table 4. Naldemedine Industry Restraints Table 5. Global Naldemedine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Naldemedine Revenue Share by Company (2021-2026) Table 7. Global Naldemedine Sales Volume by Company (k pcs) & (2021-2026) Table 8. Global Naldemedine Sales Volume Share by Company (2021-2026) Table 9. Global Naldemedine Average Price (US$/pcs) of Company (2021-2026) Table 10. Global Naldemedine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Naldemedine Key Company Manufacturing Base & Headquarters Table 12. Global Naldemedine Company, Product Type & Application Table 13. Global Naldemedine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Naldemedine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Self-production API Table 18. Significant Companies of Outsourcing of API Table 19. Global Naldemedine Sales Volume by Type 2021 VS 2025 VS 2032 (k pcs) Table 20. Global Naldemedine Sales Volume by Type (2021-2026) & (k pcs) Table 21. Global Naldemedine Sales Volume by Type (2027-2032) & (k pcs) Table 22. Global Naldemedine Sales Volume Share by Type (2021-2026) Table 23. Global Naldemedine Sales Volume Share by Type (2027-2032) Table 24. Global Naldemedine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Naldemedine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Naldemedine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Naldemedine Sales Value Share by Type (2021-2026) Table 28. Global Naldemedine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Clinic Table 30. Significant Companies of Hospital Table 31. Significant Companies of Drug Center Table 32. Significant Companies of Others Table 33. Global Naldemedine Sales Volume by Application 2021 VS 2025 VS 2032 (k pcs) Table 34. Global Naldemedine Sales Volume by Application (2021-2026) & (k pcs) Table 35. Global Naldemedine Sales Volume by Application (2027-2032) & (k pcs) Table 36. Global Naldemedine Sales Volume Share by Application (2021-2026) Table 37. Global Naldemedine Sales Volume Share by Application (2027-2032) Table 38. Global Naldemedine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Naldemedine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Naldemedine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Naldemedine Sales Value Share by Application (2021-2026) Table 42. Global Naldemedine Sales Value Share by Application (2027-2032) Table 43. Global Naldemedine Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Table 44. Global Naldemedine Sales by Region (2021-2026) & (k pcs) Table 45. Global Naldemedine Sales Market Share by Region (2021-2026) Table 46. Global Naldemedine Sales by Region (2027-2032) & (k pcs) Table 47. Global Naldemedine Sales Market Share by Region (2027-2032) Table 48. Global Naldemedine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Naldemedine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Naldemedine Sales Value Share by Region (2021-2026) Table 51. Global Naldemedine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Naldemedine Sales Value Share by Region (2027-2032) Table 53. Global Naldemedine Market Average Price (US$/pcs) by Region (2021-2026) Table 54. Global Naldemedine Market Average Price (US$/pcs) by Region (2027-2032) Table 55. Global Naldemedine Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Table 56. Global Naldemedine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Naldemedine Sales by Country (2021-2026) & (k pcs) Table 58. Global Naldemedine Sales Market Share by Country (2021-2026) Table 59. Global Naldemedine Sales by Country (2027-2032) & (k pcs) Table 60. Global Naldemedine Sales Market Share by Country (2027-2032) Table 61. Global Naldemedine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Naldemedine Sales Value Market Share by Country (2021-2026) Table 63. Global Naldemedine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Naldemedine Sales Value Market Share by Country (2027-2032) Table 65. Purdue Pharma Company Information Table 66. Purdue Pharma Business Overview Table 67. Purdue Pharma Naldemedine Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 68. Purdue Pharma Naldemedine Product Portfolio Table 69. Purdue Pharma Recent Development Table 70. Shionogi Company Information Table 71. Shionogi Business Overview Table 72. Shionogi Naldemedine Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 73. Shionogi Naldemedine Product Portfolio Table 74. Shionogi Recent Development Table 75. Key Raw Materials Table 76. Raw Materials Key Suppliers Table 77. Naldemedine Distributors List Table 78. Naldemedine Customers List Table 79. Research Programs/Design for This Report Table 80. Authors List of This Report Table 81. Secondary Sources Table 82. Primary Sources List of Figures Figure 1. Naldemedine Product Image Figure 2. Global Naldemedine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Naldemedine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Naldemedine Sales (2021-2032) & (k pcs) Figure 5. Global Naldemedine Sales Average Price (US$/pcs) & (2021-2032) Figure 6. Global Naldemedine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Self-production API Image Figure 10. Outsourcing of API Image Figure 11. Global Naldemedine Sales Volume by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 12. Global Naldemedine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Naldemedine Sales Volume Share by Type (2021-2032) Figure 14. Global Naldemedine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Naldemedine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Naldemedine Sales Value Share by Type (2021-2032) Figure 17. Clinic Image Figure 18. Hospital Image Figure 19. Drug Center Image Figure 20. Others Image Figure 21. Global Naldemedine Sales Volume by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 22. Global Naldemedine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Naldemedine Sales Volume Share by Application (2021-2032) Figure 24. Global Naldemedine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Naldemedine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Naldemedine Sales Value Share by Application (2021-2032) Figure 27. Global Naldemedine Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 28. Global Naldemedine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Naldemedine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Naldemedine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Naldemedine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Naldemedine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Naldemedine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Naldemedine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Naldemedine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Naldemedine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Naldemedine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Naldemedine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Naldemedine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Naldemedine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Naldemedine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Naldemedine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Naldemedine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Naldemedine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Naldemedine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Self-production API
  • Outsourcing of API
Applications
  • Clinic
  • Hospital
  • Drug Center
  • Others
Companies covered
  • Purdue Pharma
  • Shionogi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Naldemedine Sales Value (2021-2032)
  4. 1.2.2 Global Naldemedine Sales Volume (2021-2032)
  5. 1.2.3 Global Naldemedine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Naldemedine Market Dynamics
  1. 2.1 Naldemedine Industry Trends
  2. 2.2 Naldemedine Industry Drivers
  3. 2.3 Naldemedine Industry Opportunities and Challenges
  4. 2.4 Naldemedine Industry Restraints
3 Naldemedine Market by Company
  1. 3.1 Global Naldemedine Company Revenue Ranking in 2025
  2. 3.2 Global Naldemedine Revenue by Company (2021-2026)
  3. 3.3 Global Naldemedine Sales Volume by Company (2021-2026)
  4. 3.4 Global Naldemedine Average Price by Company (2021-2026)
  5. 3.5 Global Naldemedine Company Ranking (2024-2026)
  6. 3.6 Global Naldemedine Company Manufacturing Base and Headquarters
  7. 3.7 Global Naldemedine Company Product Type and Application
  8. 3.8 Global Naldemedine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Naldemedine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Naldemedine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Naldemedine Market by Type
  1. 4.1 Naldemedine Type Introduction
  2. 4.1.1 Self-production API
  3. 4.1.2 Outsourcing of API
  4. 4.2 Global Naldemedine Sales Volume by Type
  5. 4.2.1 Global Naldemedine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Naldemedine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Naldemedine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Naldemedine Sales Value by Type
  9. 4.3.1 Global Naldemedine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Naldemedine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Naldemedine Sales Value Share by Type (2021-2032)
5 Naldemedine Market by Application
  1. 5.1 Naldemedine Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Drug Center
  5. 5.1.4 Others
  6. 5.2 Global Naldemedine Sales Volume by Application
  7. 5.2.1 Global Naldemedine Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Naldemedine Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Naldemedine Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Naldemedine Sales Value by Application
  11. 5.3.1 Global Naldemedine Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Naldemedine Sales Value by Application (2021-2032)
  13. 5.3.3 Global Naldemedine Sales Value Share by Application (2021-2032)
6 Naldemedine Regional Sales and Value Analysis
  1. 6.1 Global Naldemedine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Naldemedine Sales by Region (2021-2032)
  3. 6.2.1 Global Naldemedine Sales by Region: 2021-2026
  4. 6.2.2 Global Naldemedine Sales by Region (2027-2032)
  5. 6.3 Global Naldemedine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Naldemedine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Naldemedine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Naldemedine Sales Value by Region (2027-2032)
  9. 6.5 Global Naldemedine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Naldemedine Sales Value (2021-2032)
  12. 6.6.2 North America Naldemedine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Naldemedine Sales Value (2021-2032)
  15. 6.7.2 Europe Naldemedine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Naldemedine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Naldemedine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Naldemedine Sales Value (2021-2032)
  21. 6.9.2 South America Naldemedine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Naldemedine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Naldemedine Sales Value Share by Country, 2025 VS 2032
7 Naldemedine Country-level Sales and Value Analysis
  1. 7.1 Global Naldemedine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Naldemedine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Naldemedine Sales by Country (2021-2032)
  4. 7.3.1 Global Naldemedine Sales by Country (2021-2026)
  5. 7.3.2 Global Naldemedine Sales by Country (2027-2032)
  6. 7.4 Global Naldemedine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Naldemedine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Naldemedine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Naldemedine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Naldemedine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Naldemedine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Naldemedine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Naldemedine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Naldemedine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Naldemedine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Naldemedine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Naldemedine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Naldemedine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Naldemedine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Naldemedine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Naldemedine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Naldemedine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Naldemedine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Naldemedine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Naldemedine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Naldemedine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Naldemedine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Naldemedine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Naldemedine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Naldemedine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Naldemedine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Naldemedine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Naldemedine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Naldemedine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Naldemedine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Naldemedine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Naldemedine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Naldemedine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Naldemedine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Naldemedine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Naldemedine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Naldemedine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Naldemedine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Naldemedine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Naldemedine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Naldemedine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Naldemedine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Naldemedine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Naldemedine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Naldemedine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Naldemedine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Naldemedine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Naldemedine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Naldemedine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Naldemedine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Naldemedine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Naldemedine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Naldemedine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Naldemedine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Naldemedine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Naldemedine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Naldemedine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Naldemedine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Naldemedine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Naldemedine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Naldemedine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Naldemedine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Naldemedine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Naldemedine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Naldemedine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Naldemedine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Naldemedine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Naldemedine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Naldemedine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Naldemedine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Naldemedine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Naldemedine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Naldemedine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Naldemedine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Naldemedine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Naldemedine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Naldemedine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Naldemedine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Naldemedine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Naldemedine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Naldemedine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Naldemedine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Naldemedine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Naldemedine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Naldemedine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Naldemedine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Naldemedine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Purdue Pharma
  2. 8.1.1 Purdue Pharma Company Information
  3. 8.1.2 Purdue Pharma Business Overview
  4. 8.1.3 Purdue Pharma Naldemedine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Purdue Pharma Naldemedine Product Portfolio
  6. 8.1.5 Purdue Pharma Recent Developments
  7. 8.2 Shionogi
  8. 8.2.1 Shionogi Company Information
  9. 8.2.2 Shionogi Business Overview
  10. 8.2.3 Shionogi Naldemedine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shionogi Naldemedine Product Portfolio
  12. 8.2.5 Shionogi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Naldemedine Value Chain Analysis
  2. 9.1.1 Naldemedine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Naldemedine Sales Mode & Process
  6. 9.2 Naldemedine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Naldemedine Distributors
  9. 9.2.3 Naldemedine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst